JANX

29.30

1.31% -0.39

Handel nachbörslich: 29.30

Janux Therapeutics Inc (JANX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$29.69

Offen:

$29.28

24-Stunden-Volumen:

355.15K

Relative Volume:

0.39

Marktkapitalisierung:

$1.71B

Einnahmen:

$13.05M

Nettoeinkommen (Verlust:

$-60.54M

KGV:

-25.26

EPS:

-1.16

Netto-Cashflow:

$-37.82M

1W Leistung:

+1.21%

1M Leistung:

-2.14%

6M Leistung:

-41.97%

1J Leistung:

-39.82%

1-Tages-Spanne:

$29.04

$30.84

1-Wochen-Bereich:

$27.93

$30.84

52-Wochen-Spanne:

$22.52

$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Firmenname

Janux Therapeutics Inc

Sektor

Healthcare (1155)

Branche

Biotechnology (677)

Telefon

(858) 751-4493

Adresse

10955 VISTA SORRENTO PARKWAY, SAN DIEGO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-08-06

Neueste SEC-Einreichungen

JANX's Discussions on Twitter

Vergleichen Sie JANX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
JANX Janux Therapeutics Inc	29.30	1.71B	13.05M	-60.54M	-37.82M	-1.16
VRTX Vertex Pharmaceuticals Inc	477.52	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	561.49	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	595.70	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	232.75	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	229.22	26.16B	3.81B	-644.79M	-669.77M	-6.24

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-03	Bestätigt	BTIG Research	Buy
2024-12-03	Bestätigt	H.C. Wainwright	Buy
2024-11-22	Eingeleitet	Leerink Partners	Outperform
2024-10-24	Eingeleitet	UBS	Buy
2024-09-06	Eingeleitet	Stifel	Buy
2024-05-30	Eingeleitet	Scotiabank	Sector Perform
2024-03-21	Eingeleitet	BTIG Research	Buy
2024-03-20	Eingeleitet	Cantor Fitzgerald	Overweight
2023-04-06	Eingeleitet	Wedbush	Outperform
2022-11-14	Eingeleitet	William Blair	Outperform

Alle ansehen

Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten

04:33 AM

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Invesco Ltd. - Defense World

04:33 AM

Apr 17, 2025

Long Term Trading Analysis for (JANX) - news.stocktradersdaily.com

Apr 17, 2025

Apr 16, 2025

Geode Capital Management LLC Boosts Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 16, 2025

Apr 15, 2025

JPMorgan Chase & Co. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 15, 2025

Apr 10, 2025

9,378 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Sei Investments Co. - Defense World

Apr 10, 2025

Apr 09, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 09, 2025

Apr 07, 2025

Janux Therapeutics stock hits 52-week low at $23.72 By Investing.com - Investing.com South Africa

Apr 07, 2025

Janux Therapeutics stock hits 52-week low at $23.72 - Investing.com Australia

Apr 07, 2025

Janux Therapeutics: What's My Inflection Point? (NASDAQ:JANX) - Seeking Alpha

Apr 07, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 07, 2025

Apr 05, 2025

Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout (NASDAQ:JANX) - Seeking Alpha

Apr 05, 2025

Apr 01, 2025

(JANX) Investment Report - news.stocktradersdaily.com

Apr 01, 2025

Mar 31, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Teacher Retirement System of Texas - Defense World

Mar 31, 2025

Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa

Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India

Mar 28, 2025

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Insider Monkey

Mar 28, 2025

Mar 26, 2025

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025

Mar 25, 2025